EBR Systems, Inc. (ASX: EBR) has received FDA approval of the WiSE® System, which marks a significant leap forward in the treatment of heart failure. Unlike conventional CRT, the WiSE System is the ...

EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...

Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.

Stocktwits - Shares of Adagio Medical (TASE: BLWV) Holdings, Inc. (ADGM) experienced a significant surge in retail investor ...

The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...

Adagio Medical (ADGM) announced it received Breakthrough Device designation from the FDA for its vCLAS Cryoablation System. The designation is ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle ...

Systems announced the US commercial release of its Ventrax Delivery System. The new delivery system is Merit’s latest ...

A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed an innovative gene-therapy strategy ...

MMSI launches the Ventrax Delivery System, enhancing pulmonary access procedures with improved control, precision, and efficiency for interventionalists.